ARTICLE | Management Tracks
CRISPR, Nkarta join flurry of CMO moves
Siegall leaving Seagen amid concerns over conduct; new CFO at Mirati and more
May 17, 2022 1:33 AM UTC
At least five biotechs announced CMO moves Monday, including updates from CRISPR Therapeutics AG (NASDAQ:CRSP), Nkarta Inc. (NASDAQ:NKTX) and Scholar Rock Holding Corp. (NASDAQ:SRRK) that came after the bell.
CRISPR Therapeutics hired Phuong Khanh “P.K.” Morrow as CMO, effective May 23. Morrow was most recently VP and global therapeutic area head of hematology, GI oncology, GU oncology and bone at Amgen Inc. (NASDAQ:AMGN). ...